Xvivo Perfusion AB (publ) (0RKL.L) LSE
Currency In SEK
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.82B |
| Enterprise Value | 5.76B |
| P/E Ratio | 105.64 |
| PEG Ratio | -2.29 |
| Price/Sales Ratio | 9.33 |
| Price/Book Ratio | 3.59 |
| Enterprise/Revenue | 9.11 |
| Enterprise/EBITDA | 49.37 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.09 |
| Operating Margin | 0.12 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.03 |
Income Statement
| Revenue | 812.17M |
| Revenue/Share | 26.49 |
| Gross Profit | 533.5M |
| EBITDA | 153.14M |
| Net Income | 25.16M |
| Diluted EPS | 0.8 |
Balance Sheet
| Total Cash | 308.14M |
| Total Cash/Share | 9.78 |
| Total Debt | 122.68M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 4.52 |
| Book Value Per Share | 68.87 |
Price History
| 52-Week Change | -10.34 |
| 52-Week High | 343.52 |
| 52-Week Low | 205.5 |
| Moving Average 50 Days | 291.55 |
| Moving Average 200 Days | 282.98 |
Statistics
| Average Volume | 9,843 |
| Shares Outstanding | 31.5M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
